VEEV logo

Veeva Systems Inc. (VEEV) Hisse Analizi

Yalnızca bilgilendirme amaçlıdır. Finansal tavsiye değildir. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

221.32$'dan işlem gören Veeva Systems Inc. (VEEV), 36380992149 değerindeki bir Technology şirketidir. Hisse senedi, 9 kantitatif KPI'ya dayalı olarak orta dereceli bir derecelendirme olan 55/100 puan alıyor.

Son analiz: 9 Şub 2026
55/100 AI Puanı PD 36B Hacim 2M

Veeva Systems Inc. (VEEV) Teknoloji Profili ve Rekabetçi Konumu

CEOPeter Gassner
Çalışanlar7291
MerkezPleasanton, CA, US
Halka Arz Yılı2013
SektörTechnology

Veeva Systems: The premier cloud-based software provider for the life sciences, offering a comprehensive suite of solutions that drive efficiency, compliance, and innovation, making it a compelling investment in a rapidly growing market with a $30.19B market cap.

Veri Kaynağı | Finansal Veriler Kantitatif Analiz NASDAQ Analiz: 9 Şub 2026

Yatırım Tezi

Veeva Systems presents a notable research candidate due to its dominant position in the life sciences cloud software market. The company's tailored solutions address critical needs within the pharmaceutical and biotechnology sectors, driving strong customer retention and recurring revenue. Veeva's growth is fueled by the increasing adoption of cloud technology in the life sciences industry and the company's ability to expand its product offerings and market reach. Key value drivers include Veeva's high gross margins, reflecting its software-as-a-service (SaaS) business model, and its strong cash flow generation. Upcoming catalysts include continued expansion into new product areas and geographic regions, as well as the potential for strategic acquisitions. With a market cap of $30.19B, Veeva offers investors exposure to a high-growth market with significant long-term potential.

FMP finansallarına ve nicel analizine dayanmaktadır

Temel Önemli Noktalar

  • Veeva Systems is the leading provider of cloud-based software solutions for the life sciences industry.
  • Veeva offers a comprehensive suite of software, data, and analytics solutions.
  • Veeva's solutions include CRM and content management applications.
  • Veeva's solutions are designed to streamline operations and enhance collaboration.
  • Veeva's solutions are used by a diverse range of life sciences organizations.

Rakipler & Benzerleri

Güçlü Yönler

  • Leading market position in life sciences software.
  • Comprehensive suite of integrated solutions.
  • Strong recurring revenue and high gross margins.
  • Experienced management team and deep industry expertise.

Zayıflıklar

  • Reliance on the life sciences industry.
  • Premium pricing may limit adoption by smaller companies.
  • Potential for increased competition from larger software vendors.
  • Dependence on third-party cloud infrastructure providers.

Katalizörler

  • Upcoming: New product launches to expand product offerings.
  • Ongoing: Continued expansion into international markets.
  • Ongoing: Strategic acquisitions to accelerate growth.
  • Ongoing: Increasing adoption of cloud-based solutions in life sciences.
  • Ongoing: Growing demand for data and analytics solutions.

Riskler

  • Potential: Economic downturn may impact IT spending.
  • Potential: Regulatory changes may require significant investments.
  • Potential: Cybersecurity threats and data breaches.
  • Potential: Disruptive technologies may emerge.
  • Ongoing: Competition from larger software vendors.

Büyüme Fırsatları

  • Expansion into New Product Areas: Veeva has the opportunity to expand its product offerings beyond its core CRM and content management solutions. This could include developing new applications for areas such as clinical trial management, regulatory affairs, and manufacturing. By expanding its product portfolio, Veeva can increase its addressable market and drive further revenue growth. The timeline for this growth opportunity is ongoing, as Veeva continuously invests in research and development to innovate and expand its offerings.
  • Geographic Expansion: Veeva has a significant opportunity to expand its presence in international markets. While the company already serves customers in North America, Europe, and Asia, there is potential to further penetrate these markets and enter new regions. Geographic expansion can drive revenue growth and diversify Veeva's customer base. The timeline for this growth opportunity is ongoing, as Veeva continues to invest in its global sales and marketing efforts.
  • Strategic Acquisitions: Veeva can pursue strategic acquisitions to accelerate its growth and expand its capabilities. Acquisitions can provide access to new technologies, markets, and customers. By acquiring complementary businesses, Veeva can strengthen its competitive position and enhance its product offerings. The timeline for this growth opportunity is ongoing, as Veeva actively evaluates potential acquisition targets.
  • Data and Analytics Solutions: Veeva has the opportunity to further develop its data and analytics solutions. By leveraging its vast data assets, Veeva can provide valuable insights to its customers, helping them to make better decisions and improve their business outcomes. The market for data and analytics solutions in the life sciences industry is growing rapidly, and Veeva is well-positioned to capitalize on this trend. The timeline for this growth opportunity is ongoing, as Veeva continues to invest in its data and analytics capabilities.
  • Partnerships and Integrations: Veeva can leverage partnerships and integrations to expand its reach and enhance its product offerings. By partnering with other technology providers, Veeva can offer its customers a more comprehensive solution. Integrations with other systems can also improve efficiency and reduce costs. The timeline for this growth opportunity is ongoing, as Veeva actively seeks out new partnerships and integrations.

Fırsatlar

  • Expansion into new product areas and geographic regions.
  • Strategic acquisitions to accelerate growth.
  • Increased adoption of cloud-based solutions in life sciences.
  • Growing demand for data and analytics solutions.

Tehditler

  • Economic downturn may impact IT spending.
  • Regulatory changes may require significant investments.
  • Cybersecurity threats and data breaches.
  • Disruptive technologies may emerge.

Rekabet Avantajları

  • High switching costs due to integrated platform.
  • Strong brand reputation and customer loyalty.
  • Deep industry expertise and regulatory knowledge.
  • Extensive data assets and network effects.

VEEV Hakkında

Veeva Systems Inc., founded in 2007, emerged with a clear vision: to revolutionize the life sciences industry through cloud-based software solutions. Recognizing the unique challenges faced by pharmaceutical and biotechnology companies, Veeva developed a suite of applications designed to streamline operations, enhance collaboration, and accelerate innovation. From its inception, Veeva has been committed to providing tailored solutions that address the specific needs of the life sciences sector. Today, Veeva stands as a dominant force in the industry, offering a comprehensive portfolio of software, data, and analytics solutions. Its flagship products include Veeva CRM, a customer relationship management platform designed to optimize sales and marketing efforts; Veeva Vault, a unified content management and collaboration platform; and Veeva Network, a comprehensive data management solution. These solutions empower life sciences companies to manage their critical business processes, from clinical trials and regulatory submissions to commercial operations and medical affairs. Veeva's solutions are utilized by a diverse range of life sciences organizations, from emerging biotech startups to global pharmaceutical giants. The company's commitment to innovation and customer success has earned it a reputation as a trusted partner in the industry. With a strong focus on cloud-based technology, Veeva enables its customers to operate more efficiently, reduce costs, and bring life-saving therapies to market faster. Veeva continues to expand its global presence, serving customers in North America, Europe, Asia, and beyond.

Ne Yaparlar

  • Provides cloud-based software solutions for the life sciences industry.
  • Offers a suite of CRM applications to manage customer relationships.
  • Provides content management applications to streamline regulatory submissions.
  • Offers data and analytics solutions to improve decision-making.
  • Helps life sciences companies manage clinical trials more efficiently.
  • Enables better collaboration among teams within life sciences organizations.
  • Streamlines commercial operations for pharmaceutical companies.

İş Modeli

  • Software-as-a-Service (SaaS) subscription model.
  • Recurring revenue through annual contracts.
  • Pricing based on the number of users and modules.
  • Professional services for implementation and training.

Sektör Bağlamı

Veeva Systems operates within the rapidly growing life sciences software market. The industry is characterized by increasing adoption of cloud-based solutions, driven by the need for greater efficiency, collaboration, and regulatory compliance. Veeva is well-positioned to capitalize on these trends, with its comprehensive suite of tailored solutions and its strong reputation in the industry. The competitive landscape includes both large enterprise software vendors and smaller, specialized providers. Veeva differentiates itself through its deep industry expertise and its focus on meeting the unique needs of life sciences companies.

Kilit Müşteriler

  • Pharmaceutical companies
  • Biotechnology companies
  • Medical device companies
  • Contract research organizations (CROs)
AI Güveni: 63% Güncellendi: 9 Şub 2026

Finansallar

Grafik & Bilgi

Veeva Systems Inc. (VEEV) hisse senedi fiyatı: $221.32 (+1.83, +0.83%)

Son Haberler

Analist Konsensüsü

Fikir Birliği Derecelendirmesi

VEEV için Benzinga, Yahoo Finance ve Finnhub'dan toplanan Al/Tut/Sat önerileri.

Fiyat Hedefleri

VEEV için Wall Street fiyat hedefi analizi.

MoonshotScore

55/100

Bu puan ne anlama geliyor?

MoonshotScore, VEEV'ın büyüme potansiyelini inovasyon, pazar yıkımı, finansal sağlık ve momentum dahil olmak üzere birden fazla faktörde 0-100 ölçeğinde derecelendirir.

VEEV Technology Hisse Senedi SSS

VEEV için değerlendirilmesi gereken temel faktörler nelerdir?

Veeva Systems Inc. (VEEV) şu anda yapay zeka skoru 55/100, orta puanı gösteriyor. Temel güçlü yan: Leading market position in life sciences software.. İzlenmesi gereken birincil risk: Potential: Economic downturn may impact IT spending.. Bu bir finansal tavsiye değildir.

VEEV MoonshotScore'u nedir?

VEEV şu anda MoonshotScore'da 55/100 (Derece C) alıyor, bu da orta derecelendirme gösteriyor. Puan, 9 kantitatif KPI genelinde büyüme potansiyelini, finansal sağlığı, piyasa momentumunu ve risk faktörlerini değerlendirir. En son piyasa verileri kullanılarak günlük olarak yeniden hesaplanır. Bu puan yalnızca bilgilendirme amaçlıdır.

VEEV verileri ne sıklıkla güncellenir?

VEEV fiyatları ABD piyasa saatleri (hafta içi 9:30-16:00 ET) sırasında gerçek zamanlı olarak güncellenir. Temeller, üç aylık veya yıllık beyanlardan sonra yenilenir. Analist derecelendirmeleri ve yapay zeka öngörüleri günlük olarak güncellenir. Haberler, finans kaynaklarından sürekli olarak toplanır.

Analistler VEEV hakkında ne diyor?

VEEV için analist kapsamı, büyük araştırma şirketlerinden fikir birliği derecelendirmelerini (al, tut, sat), 12 aylık fiyat hedeflerini ve kazanç tahminlerini içerir. Temel veri noktaları: fikir birliği hedef fiyatı, kapsayan analist sayısı, son yükseltmeler veya düşürmeler ve kazanç beklentilerini aşma/aşamama geçmişi. Bu sayfadaki Analist Konsensüsü bölümüne bakın.

VEEV'a yatırım yapmanın riskleri nelerdir?

VEEV için risk kategorileri arasında piyasa riski, şirkete özgü risk (yönetim, rekabet), finansal risk (borç, nakit yakımı) ve makroekonomik risk (oranlar, enflasyon) yer alır. Yapay zeka analizi tarafından belirlenen önemli bir risk: Potential: Economic downturn may impact IT spending.. 1,0'ın üzerindeki beta, S&P 500'den daha yüksek volatiliteyi gösterir. Ayrıntılar için bu sayfadaki Risk Faktörleri bölümünü inceleyin. Tüm yatırımlar kayıp riski taşır.

VEEV'ın P/E oranı nedir?

VEEV için P/E (fiyat-kazanç) oranı, mevcut hisse senedi fiyatını hisse başına kazancıyla karşılaştırır. Daha yüksek bir P/E büyüme beklentilerini gösterebilirken, daha düşük bir P/E değer veya azalan kazançlar gösterebilir. Anlamlı bir bağlam için VEEV'ın P/E'sini sektördeki emsalleriyle ve S&P 500 ortalamasıyla karşılaştırın. Mevcut değerleme metrikleri için Finansallar sekmesini kontrol edin.

VEEV aşırı değerli mi, yoksa düşük değerli mi?

Veeva Systems Inc. (VEEV)'ın aşırı değerli mi yoksa düşük değerli mi olduğunu belirlemek, birden fazla metriği incelemeyi gerektirir. Kapsamlı bir görünüm için değerleme oranlarını (P/E, P/S, EV/EBITDA) sektördeki emsallerle karşılaştırın. Bu bir finansal tavsiye değildir.

VEEV'ın temettü verimi nedir?

Veeva Systems Inc. (VEEV) şu anda düzenli bir temettü ödemiyor veya temettü verimi verileri mevcut değil. Büyüme odaklı şirketler genellikle temettü ödemek yerine karları yeniden yatırır. En son temettü bilgileri ve ödeme geçmişi için Finansallar sekmesini kontrol edin.

Sorumluluk reddi: Bu içerik yalnızca bilgilendirme amaçlıdır ve yatırım tavsiyesi teşkil etmez. Her zaman kendi araştırmanızı yapın ve bir finans uzmanına danışın.

Resmi Kaynaklar

Analiz güncellendi AI Puanı günlük olarak yenilenir
Veri Kaynakları ve Metodoloji
Piyasa verileri Financial Modeling Prep ve Yahoo Finance tarafından sağlanmaktadır. AI analizi Stock Expert AI tescilli algoritmaları ile yapılmaktadır. Teknik göstergeler endüstri standardı hesaplamalarla üretilmektedir. Son güncelleme: .

Veriler yalnızca bilgilendirme amaçlı sağlanmıştır.

Analiz Notları
  • Information is based on available data and may be subject to change.
  • Investment decisions should be based on thorough research and consultation with a financial advisor.
Veri Kaynakları

Popüler Hisseler